Total Payments
$568.42
2024 Payments
$160.18
Companies
12
Transactions
32
Medicare Patients
1,800
Medicare Billing
$67,589
Payment Breakdown by Category
Food & Beverage$568.42 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $568.42 | 32 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $197.12 | 11 | $0 (2024) |
| Novo Nordisk Inc | $87.42 | 5 | $0 (2024) |
| Lilly USA, LLC | $53.90 | 3 | $0 (2024) |
| Abbott Laboratories | $43.11 | 2 | $0 (2022) |
| GlaxoSmithKline, LLC. | $40.10 | 2 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $30.05 | 2 | $0 (2023) |
| Exact Sciences Corporation | $29.11 | 2 | $0 (2024) |
| Janssen Biotech, Inc. | $22.33 | 1 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $18.66 | 1 | $0 (2022) |
| Insmed, Inc. | $17.79 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $160.18 | 8 | Lilly USA, LLC ($41.63) |
| 2023 | $147.98 | 8 | ABBVIE INC. ($47.01) |
| 2022 | $260.26 | 16 | ABBVIE INC. ($116.78) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Respiratory | ||||||
| 08/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $33.33 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Diabetes | ||||||
| 06/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Diabetes | ||||||
| 04/15/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Immunology | ||||||
| 02/27/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Oncology | ||||||
| 12/16/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: NEUROSCIENCE | ||||||
| 11/02/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Cardio-renal | ||||||
| 06/13/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: RESPIRATORY | ||||||
| 05/11/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $30.85 | General |
| Category: NEUROSCIENCE | ||||||
| 04/20/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.12 | General |
| 03/13/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Diabetes | ||||||
| 02/27/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Neurology | ||||||
| 01/24/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Cardio-renal | ||||||
| 11/22/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Diabetes | ||||||
| 11/17/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Diabetes | ||||||
| 11/10/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: VACCINES | ||||||
| 10/26/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Gastroenterology | ||||||
| 10/20/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: HYPERHYDROSIS | ||||||
| 10/20/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: NEUROSCIENCE | ||||||
| 10/06/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: NEUROSCIENCE | ||||||
| 09/29/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: HYPERHYDROSIS | ||||||
| 09/15/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 373 | 395 | $71,981 | $16,022 |
| 2022 | 10 | 465 | 566 | $79,470 | $16,667 |
| 2021 | 16 | 809 | 842 | $104,063 | $29,824 |
| 2020 | 3 | 153 | 177 | $26,917 | $5,076 |
Total Patients
1,800
Total Services
1,980
Medicare Billing
$67,589
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 208 | 221 | $42,874 | $9,292 | 21.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 88 | 89 | $25,632 | $6,007 | 23.4% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 12 | 13 | $533.00 | $210.60 | 39.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 21 | 23 | $575.00 | $193.20 | 33.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 20 | 20 | $1,620 | $170.51 | 10.5% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 11 | 11 | $297.00 | $87.01 | 29.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 13 | 18 | $450.00 | $61.38 | 13.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 285 | 347 | $67,318 | $14,469 | 21.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 16 | $4,608 | $1,067 | 23.1% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 22 | 23 | $943.00 | $375.54 | 39.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 54 | 62 | $1,550 | $213.14 | 13.8% |
| 87086 | Bacterial colony count, urine | Office | 2022 | 20 | 20 | $540.00 | $160.20 | 29.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 18 | 19 | $1,311 | $140.10 | 10.7% |
| 90471 | Administration of vaccine | Office | 2022 | 11 | 11 | $660.00 | $117.28 | 17.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 15 | 15 | $1,215 | $80.28 | 6.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 11 | 11 | $275.00 | $32.70 | 11.9% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2022 | 13 | 42 | $1,050 | $11.79 | 1.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 223 | 242 | $46,948 | $12,845 | 27.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 104 | 108 | $31,104 | $9,480 | 30.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 19 | 19 | $5,928 | $2,252 | 38.0% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 13 | 13 | $1,485 | $863.59 | 58.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 64 | 64 | $2,880 | $846.90 | 29.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 67 | 69 | $3,036 | $720.70 | 23.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 62 | 64 | $1,664 | $491.44 | 29.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 27 | 27 | $1,539 | $453.60 | 29.5% |
About Mark Mozingo
Mark Mozingo is a Medical healthcare provider based in Hollywood, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427077882.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mark Mozingo has received a total of $568.42 in payments from pharmaceutical and medical device companies, with $160.18 received in 2024. These payments were reported across 32 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($568.42).
As a Medicare-enrolled provider, Mozingo has provided services to 1,800 Medicare beneficiaries, totaling 1,980 services with total Medicare billing of $67,589. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location Hollywood, MD
- Active Since 07/18/2006
- Last Updated 07/08/2007
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1427077882
Products in Payments
- QULIPTA (Drug) $67.29
- VRAYLAR (Drug) $62.16
- Rybelsus (Drug) $56.31
- MOUNJARO (Drug) $53.90
- FREESTYLE LIBRE 2 (Device) $43.11
- BOTOX (Biological) $36.82
- UBRELVY (Drug) $30.85
- Kerendia (Drug) $30.05
- Cologuard Collection Kit (Device) $29.11
- AREXVY (Drug) $23.99
- STELARA (Biological) $22.33
- SOLIQUA 100/33 (Biological) $18.66
- Arikayce (Drug) $17.79
- SHINGRIX (Biological) $16.11
- Ozempic (Drug) $15.99
- XIFAXAN (Drug) $15.69
- Sunosi (Drug) $13.14
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Hollywood
Miss. Courtney Lennon, Pa-C, PA-C
Medical — Payments: $8,667
Medical $8,667
Pamela Miller, Pa-C, PA-C
Medical — Payments: $5,637
Medical $5,637
Mr. Maurice Adkins, P.a, P.A
Medical — Payments: $3,134
Medical $3,134
Mr. Kevin Verde, Mms, Pa-C, MMS, PA-C
Medical — Payments: $3,122
Medical $3,122
Alisa Matouka, Pa-C, PA-C
Medical — Payments: $2,757
Medical $2,757
Ms. Claudia Cortes, P.a, P.A
Medical — Payments: $2,334
Medical $2,334